Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2024 Annual Meeting | C173 - Cognitive, Behavioral, and Disease-modifying Therapeutics in Dementia

Wednesday 04/17/24
03:30 PM - 05:30 PM MDT Add To Calendar
Colorado Convention Center | Bluebird 2E-H
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Meredith Wicklund, MD, FAAN
Aging, Dementia, Cognitive, and Behavioral Neurology
Participants should become familiar with the indication for and clinical utility of pharmacological and non-pharmacological therapeutics for dementia related cognitive and behavioral symptoms, and become familiar with the first ever disease modifying treatments for dementia and their role in clinical practice.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Systems-based Practice
Introductory
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
03:30 PM - 04:05 PM MDT Speaker Non-pharmacological Treatments in Dementia
Julio C. Rojas-Martinez, MD, PhD
04:05 PM - 04:40 PM MDT Speaker Pharmacological Treatments in Dementia
Lealani Mae Acosta, MD, MPH, FAAN
04:40 PM - 05:15 PM MDT Speaker Disease Modifying Treatments in Dementia
Meredith Wicklund, MD, FAAN
05:15 PM - 05:30 PM MDT Q&A Questions & Answers
Meredith Wicklund, MD, FAAN, Julio C. Rojas-Martinez, MD, PhD, Lealani Mae Acosta, MD, MPH, FAAN
Faculty Disclosures
Meredith Wicklund, MD, FAAN The institution of Dr. Wicklund has received research support from Arizona Alzheimer's Consortium. The institution of Dr. Wicklund has received research support from NIH.
Julio C. Rojas-Martinez, MD, PhD The institution of Dr. Rojas-Martinez has received research support from NIH/NIA. The institution of Dr. Rojas-Martinez has received research support from Eli Lilly. The institution of Dr. Rojas-Martinez has received research support from Eisai. Dr. Rojas-Martinez has received research support from Roon, Healthcare. The institution of Dr. Rojas-Martinez has received research support from Amylyx.
Lealani Mae Acosta, MD, MPH, FAAN Dr. Acosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Acosta has received research support from AbbVie, Biohaven, Roche, NIH.